These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 18583542

  • 1. SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression.
    Vieira NM, Bueno CR, Brandalise V, Moraes LV, Zucconi E, Secco M, Suzuki MF, Camargo MM, Bartolini P, Brum PC, Vainzof M, Zatz M.
    Stem Cells; 2008 Sep; 26(9):2391-8. PubMed ID: 18583542
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP.
    Nature; 2003 May 08; 423(6936):168-72. PubMed ID: 12736685
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Autosomal recessive limb-girdle muscular dystrophy].
    Hernández-Caballero ME, Miranda-Duarte A, Escobar-Cedillo RE, Villegas-Castrejon H.
    Rev Neurol; 2010 Oct 16; 51(8):489-96. PubMed ID: 20925031
    [Abstract] [Full Text] [Related]

  • 7. Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).
    Suzuki N, Aoki M, Hinuma Y, Takahashi T, Onodera Y, Ishigaki A, Kato M, Warita H, Tateyama M, Itoyama Y.
    Neurosci Res; 2005 May 16; 52(1):47-60. PubMed ID: 15811552
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dysferlin and muscular dystrophy.
    Bushby KM.
    Acta Neurol Belg; 2000 Sep 16; 100(3):142-5. PubMed ID: 11098285
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The distribution and characterization of skeletal muscle lesions in dysferlin-deficient SJL and A/J mice.
    Kobayashi K, Izawa T, Kuwamura M, Yamate J.
    Exp Toxicol Pathol; 2010 Sep 16; 62(5):509-17. PubMed ID: 19615872
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
    Au CG, Butler TL, Egan JR, Cooper ST, Lo HP, Compton AG, North KN, Winlaw DS.
    Acta Neuropathol; 2008 Sep 16; 116(3):235-46. PubMed ID: 18392839
    [Abstract] [Full Text] [Related]

  • 16. Limb-girdle muscular dystrophy due to emerin gene mutations.
    Ura S, Hayashi YK, Goto K, Astejada MN, Murakami T, Nagato M, Ohta S, Daimon Y, Takekawa H, Hirata K, Nonaka I, Noguchi S, Nishino I.
    Arch Neurol; 2007 Jul 16; 64(7):1038-41. PubMed ID: 17620497
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular etiopathogenesis of limb girdle muscular and congenital muscular dystrophies: boundaries and contiguities.
    Guglieri M, Magri F, Comi GP.
    Clin Chim Acta; 2005 Nov 16; 361(1-2):54-79. PubMed ID: 16002060
    [Abstract] [Full Text] [Related]

  • 19. Characterisation of the dysferlin skeletal muscle promoter.
    Foxton RM, Laval SH, Bushby KM.
    Eur J Hum Genet; 2004 Feb 16; 12(2):127-31. PubMed ID: 14560310
    [Abstract] [Full Text] [Related]

  • 20. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis.
    Lo HP, Cooper ST, Evesson FJ, Seto JT, Chiotis M, Tay V, Compton AG, Cairns AG, Corbett A, MacArthur DG, Yang N, Reardon K, North KN.
    Neuromuscul Disord; 2008 Jan 16; 18(1):34-44. PubMed ID: 17897828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.